nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—artery—atherosclerosis	0.0783	0.301	CbGeAlD
Lubiprostone—CLCN2—endothelium—atherosclerosis	0.0662	0.254	CbGeAlD
Lubiprostone—CLCN2—blood vessel—atherosclerosis	0.061	0.235	CbGeAlD
Lubiprostone—CLCN2—cardiovascular system—atherosclerosis	0.0272	0.105	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—LTA4H—atherosclerosis	0.0198	0.0804	CbGpPWpGaD
Lubiprostone—CLCN2—Stimuli-sensing channels—TRPV1—atherosclerosis	0.0178	0.0724	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—ALOX5AP—atherosclerosis	0.0124	0.0505	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—ALOX15—atherosclerosis	0.0124	0.0505	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—TRPV1—atherosclerosis	0.0116	0.0473	CbGpPWpGaD
Lubiprostone—CBR1—cardiovascular system—atherosclerosis	0.0109	0.042	CbGeAlD
Lubiprostone—Faecal incontinence—Niacin—atherosclerosis	0.0106	0.0215	CcSEcCtD
Lubiprostone—CBR1—Arachidonic acid metabolism—ALOX5—atherosclerosis	0.0105	0.0429	CbGpPWpGaD
Lubiprostone—CBR1—adipose tissue—atherosclerosis	0.00962	0.037	CbGeAlD
Lubiprostone—Upset stomach—Lovastatin—atherosclerosis	0.00952	0.0193	CcSEcCtD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—atherosclerosis	0.00912	0.0371	CbGpPWpGaD
Lubiprostone—Upset stomach—Simvastatin—atherosclerosis	0.00891	0.018	CcSEcCtD
Lubiprostone—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00677	0.0137	CcSEcCtD
Lubiprostone—CBR1—liver—atherosclerosis	0.00675	0.026	CbGeAlD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.00654	0.0266	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.00627	0.0255	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—GPX1—atherosclerosis	0.0056	0.0228	CbGpPWpGaD
Lubiprostone—Eructation—Niacin—atherosclerosis	0.00526	0.0106	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	0.00496	0.0202	CbGpPWpGaD
Lubiprostone—Swelling—Simvastatin—atherosclerosis	0.0048	0.00971	CcSEcCtD
Lubiprostone—Influenza—Rosuvastatin—atherosclerosis	0.00462	0.00934	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	0.00449	0.0183	CbGpPWpGaD
Lubiprostone—Cramp muscle—Lovastatin—atherosclerosis	0.00408	0.00825	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	0.00404	0.0164	CbGpPWpGaD
Lubiprostone—Urinary tract infection—Rosuvastatin—atherosclerosis	0.004	0.0081	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.004	0.00809	CcSEcCtD
Lubiprostone—Cramp muscle—Ezetimibe—atherosclerosis	0.004	0.00809	CcSEcCtD
Lubiprostone—Gastritis—Ezetimibe—atherosclerosis	0.00393	0.00795	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.00392	0.00792	CcSEcCtD
Lubiprostone—Influenza—Lovastatin—atherosclerosis	0.00391	0.00792	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	0.00389	0.0158	CbGpPWpGaD
Lubiprostone—Influenza—Ezetimibe—atherosclerosis	0.00384	0.00777	CcSEcCtD
Lubiprostone—Cramp muscle—Simvastatin—atherosclerosis	0.00381	0.00772	CcSEcCtD
Lubiprostone—Abdominal discomfort—Lovastatin—atherosclerosis	0.00375	0.00759	CcSEcCtD
Lubiprostone—Gastritis—Simvastatin—atherosclerosis	0.00375	0.00758	CcSEcCtD
Lubiprostone—Abdominal discomfort—Simvastatin—atherosclerosis	0.00351	0.0071	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.00346	0.0141	CbGpPWpGaD
Lubiprostone—Cramp muscle—Pravastatin—atherosclerosis	0.00345	0.00698	CcSEcCtD
Lubiprostone—Urinary tract infection—Lovastatin—atherosclerosis	0.00339	0.00686	CcSEcCtD
Lubiprostone—Abdominal distension—Niacin—atherosclerosis	0.00338	0.00685	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.00338	0.00683	CcSEcCtD
Lubiprostone—Influenza—Niacin—atherosclerosis	0.00336	0.0068	CcSEcCtD
Lubiprostone—Abdominal distension—Pravastatin—atherosclerosis	0.00333	0.00674	CcSEcCtD
Lubiprostone—Influenza—Pravastatin—atherosclerosis	0.00331	0.0067	CcSEcCtD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—atherosclerosis	0.0033	0.0134	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00326	0.0133	CbGpPWpGaD
Lubiprostone—Mental disorder—Rosuvastatin—atherosclerosis	0.00324	0.00655	CcSEcCtD
Lubiprostone—Flatulence—Rosuvastatin—atherosclerosis	0.00317	0.00641	CcSEcCtD
Lubiprostone—Oedema peripheral—Ezetimibe—atherosclerosis	0.00303	0.00612	CcSEcCtD
Lubiprostone—Connective tissue disorder—Ezetimibe—atherosclerosis	0.00302	0.00611	CcSEcCtD
Lubiprostone—Weight increased—Pravastatin—atherosclerosis	0.00301	0.00609	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CETP—atherosclerosis	0.00288	0.0117	CbGpPWpGaD
Lubiprostone—Urinary tract infection—Pravastatin—atherosclerosis	0.00287	0.0058	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.00282	0.0115	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.00282	0.0115	CbGpPWpGaD
Lubiprostone—Cough—Rosuvastatin—atherosclerosis	0.00281	0.00568	CcSEcCtD
Lubiprostone—Mediastinal disorder—Ezetimibe—atherosclerosis	0.00277	0.0056	CcSEcCtD
Lubiprostone—Myalgia—Rosuvastatin—atherosclerosis	0.00274	0.00554	CcSEcCtD
Lubiprostone—Mental disorder—Ezetimibe—atherosclerosis	0.00269	0.00545	CcSEcCtD
Lubiprostone—Flatulence—Lovastatin—atherosclerosis	0.00269	0.00544	CcSEcCtD
Lubiprostone—Erythema—Ezetimibe—atherosclerosis	0.00268	0.00541	CcSEcCtD
Lubiprostone—Malnutrition—Ezetimibe—atherosclerosis	0.00268	0.00541	CcSEcCtD
Lubiprostone—Dysgeusia—Lovastatin—atherosclerosis	0.00267	0.0054	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—HMOX1—atherosclerosis	0.00266	0.0108	CbGpPWpGaD
Lubiprostone—Oedema peripheral—Niacin—atherosclerosis	0.00265	0.00536	CcSEcCtD
Lubiprostone—Flatulence—Ezetimibe—atherosclerosis	0.00264	0.00533	CcSEcCtD
Lubiprostone—Muscle spasms—Lovastatin—atherosclerosis	0.00262	0.0053	CcSEcCtD
Lubiprostone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00258	0.00521	CcSEcCtD
Lubiprostone—Muscle spasms—Ezetimibe—atherosclerosis	0.00257	0.0052	CcSEcCtD
Lubiprostone—Mental disorder—Simvastatin—atherosclerosis	0.00257	0.00519	CcSEcCtD
Lubiprostone—Tremor—Lovastatin—atherosclerosis	0.00256	0.00517	CcSEcCtD
Lubiprostone—Erythema—Simvastatin—atherosclerosis	0.00255	0.00516	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLAT—atherosclerosis	0.00254	0.0103	CbGpPWpGaD
Lubiprostone—Ill-defined disorder—Lovastatin—atherosclerosis	0.00253	0.00512	CcSEcCtD
Lubiprostone—Flatulence—Simvastatin—atherosclerosis	0.00251	0.00508	CcSEcCtD
Lubiprostone—Dysgeusia—Simvastatin—atherosclerosis	0.0025	0.00505	CcSEcCtD
Lubiprostone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00248	0.00502	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—GSTM1—atherosclerosis	0.00248	0.0101	CbGpPWpGaD
Lubiprostone—Malaise—Lovastatin—atherosclerosis	0.00246	0.00497	CcSEcCtD
Lubiprostone—Muscle spasms—Simvastatin—atherosclerosis	0.00245	0.00496	CcSEcCtD
Lubiprostone—Malaise—Ezetimibe—atherosclerosis	0.00241	0.00488	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00239	0.00484	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—AGER—atherosclerosis	0.00239	0.00974	CbGpPWpGaD
Lubiprostone—Tremor—Simvastatin—atherosclerosis	0.00239	0.00483	CcSEcCtD
Lubiprostone—Ill-defined disorder—Simvastatin—atherosclerosis	0.00237	0.00479	CcSEcCtD
Lubiprostone—Palpitations—Ezetimibe—atherosclerosis	0.00236	0.00478	CcSEcCtD
Lubiprostone—Erythema—Niacin—atherosclerosis	0.00234	0.00474	CcSEcCtD
Lubiprostone—Malnutrition—Niacin—atherosclerosis	0.00234	0.00474	CcSEcCtD
Lubiprostone—Cough—Ezetimibe—atherosclerosis	0.00233	0.00472	CcSEcCtD
Lubiprostone—Chest pain—Lovastatin—atherosclerosis	0.00232	0.0047	CcSEcCtD
Lubiprostone—Myalgia—Lovastatin—atherosclerosis	0.00232	0.0047	CcSEcCtD
Lubiprostone—Anxiety—Lovastatin—atherosclerosis	0.00231	0.00468	CcSEcCtD
Lubiprostone—Dyspepsia—Rosuvastatin—atherosclerosis	0.00231	0.00468	CcSEcCtD
Lubiprostone—Flatulence—Niacin—atherosclerosis	0.00231	0.00467	CcSEcCtD
Lubiprostone—Malaise—Simvastatin—atherosclerosis	0.0023	0.00465	CcSEcCtD
Lubiprostone—Discomfort—Lovastatin—atherosclerosis	0.00229	0.00464	CcSEcCtD
Lubiprostone—Chest pain—Ezetimibe—atherosclerosis	0.00228	0.00461	CcSEcCtD
Lubiprostone—Myalgia—Ezetimibe—atherosclerosis	0.00228	0.00461	CcSEcCtD
Lubiprostone—Flatulence—Pravastatin—atherosclerosis	0.00227	0.0046	CcSEcCtD
Lubiprostone—Dry mouth—Lovastatin—atherosclerosis	0.00227	0.00459	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00226	0.00457	CcSEcCtD
Lubiprostone—Dysgeusia—Pravastatin—atherosclerosis	0.00226	0.00457	CcSEcCtD
Lubiprostone—Muscle spasms—Niacin—atherosclerosis	0.00225	0.00456	CcSEcCtD
Lubiprostone—Discomfort—Ezetimibe—atherosclerosis	0.00225	0.00455	CcSEcCtD
Lubiprostone—Constipation—Rosuvastatin—atherosclerosis	0.00225	0.00454	CcSEcCtD
Lubiprostone—Pain—Rosuvastatin—atherosclerosis	0.00225	0.00454	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.00223	0.00909	CbGpPWpGaD
Lubiprostone—Dry mouth—Ezetimibe—atherosclerosis	0.00223	0.00451	CcSEcCtD
Lubiprostone—Muscle spasms—Pravastatin—atherosclerosis	0.00222	0.00449	CcSEcCtD
Lubiprostone—Chest pain—Simvastatin—atherosclerosis	0.00217	0.00439	CcSEcCtD
Lubiprostone—Myalgia—Simvastatin—atherosclerosis	0.00217	0.00439	CcSEcCtD
Lubiprostone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00216	0.00438	CcSEcCtD
Lubiprostone—Anxiety—Simvastatin—atherosclerosis	0.00216	0.00438	CcSEcCtD
Lubiprostone—Tremor—Pravastatin—atherosclerosis	0.00216	0.00437	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PLG—atherosclerosis	0.00216	0.00878	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00215	0.00434	CcSEcCtD
Lubiprostone—Discomfort—Simvastatin—atherosclerosis	0.00215	0.00434	CcSEcCtD
Lubiprostone—Nervous system disorder—Ezetimibe—atherosclerosis	0.00214	0.00433	CcSEcCtD
Lubiprostone—Ill-defined disorder—Pravastatin—atherosclerosis	0.00214	0.00433	CcSEcCtD
Lubiprostone—CBR1—NRF2 pathway—PDGFB—atherosclerosis	0.00213	0.00869	CbGpPWpGaD
Lubiprostone—Anorexia—Lovastatin—atherosclerosis	0.00212	0.00429	CcSEcCtD
Lubiprostone—Skin disorder—Ezetimibe—atherosclerosis	0.00212	0.00429	CcSEcCtD
Lubiprostone—Syncope—Niacin—atherosclerosis	0.0021	0.00425	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.0021	0.00854	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.0021	0.00854	CbGpPWpGaD
Lubiprostone—Oedema—Simvastatin—atherosclerosis	0.00208	0.00421	CcSEcCtD
Lubiprostone—Malaise—Pravastatin—atherosclerosis	0.00208	0.00421	CcSEcCtD
Lubiprostone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00208	0.0042	CcSEcCtD
Lubiprostone—Palpitations—Niacin—atherosclerosis	0.00207	0.00419	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.00206	0.00839	CbGpPWpGaD
Lubiprostone—Loss of consciousness—Niacin—atherosclerosis	0.00206	0.00416	CcSEcCtD
Lubiprostone—Cough—Niacin—atherosclerosis	0.00204	0.00413	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00203	0.0041	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.00202	0.00824	CbGpPWpGaD
Lubiprostone—Cough—Pravastatin—atherosclerosis	0.00201	0.00407	CcSEcCtD
Lubiprostone—Myalgia—Niacin—atherosclerosis	0.00199	0.00403	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	0.00199	0.00811	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00199	0.00402	CcSEcCtD
Lubiprostone—Anorexia—Simvastatin—atherosclerosis	0.00198	0.00401	CcSEcCtD
Lubiprostone—Dyspnoea—Lovastatin—atherosclerosis	0.00198	0.00401	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00198	0.00401	CcSEcCtD
Lubiprostone—Myalgia—Pravastatin—atherosclerosis	0.00196	0.00397	CcSEcCtD
Lubiprostone—Chest pain—Pravastatin—atherosclerosis	0.00196	0.00397	CcSEcCtD
Lubiprostone—Dyspepsia—Lovastatin—atherosclerosis	0.00196	0.00396	CcSEcCtD
Lubiprostone—Anxiety—Pravastatin—atherosclerosis	0.00196	0.00396	CcSEcCtD
Lubiprostone—Dry mouth—Niacin—atherosclerosis	0.00195	0.00395	CcSEcCtD
Lubiprostone—Dyspnoea—Ezetimibe—atherosclerosis	0.00195	0.00394	CcSEcCtD
Lubiprostone—Discomfort—Pravastatin—atherosclerosis	0.00194	0.00392	CcSEcCtD
Lubiprostone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00194	0.00391	CcSEcCtD
Lubiprostone—Decreased appetite—Lovastatin—atherosclerosis	0.00193	0.00391	CcSEcCtD
Lubiprostone—Dyspepsia—Ezetimibe—atherosclerosis	0.00192	0.00389	CcSEcCtD
Lubiprostone—Fatigue—Lovastatin—atherosclerosis	0.00192	0.00388	CcSEcCtD
Lubiprostone—Oedema—Niacin—atherosclerosis	0.00191	0.00387	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOB—atherosclerosis	0.00191	0.00776	CbGpPWpGaD
Lubiprostone—Constipation—Lovastatin—atherosclerosis	0.0019	0.00385	CcSEcCtD
Lubiprostone—Pain—Lovastatin—atherosclerosis	0.0019	0.00385	CcSEcCtD
Lubiprostone—Decreased appetite—Ezetimibe—atherosclerosis	0.0019	0.00384	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.0019	0.00384	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00188	0.00381	CcSEcCtD
Lubiprostone—Asthenia—Rosuvastatin—atherosclerosis	0.00188	0.00381	CcSEcCtD
Lubiprostone—Oedema—Pravastatin—atherosclerosis	0.00188	0.00381	CcSEcCtD
Lubiprostone—Fatigue—Ezetimibe—atherosclerosis	0.00188	0.00381	CcSEcCtD
Lubiprostone—Shock—Niacin—atherosclerosis	0.00188	0.0038	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.00187	0.00762	CbGpPWpGaD
Lubiprostone—Constipation—Ezetimibe—atherosclerosis	0.00187	0.00378	CcSEcCtD
Lubiprostone—Pain—Ezetimibe—atherosclerosis	0.00187	0.00378	CcSEcCtD
Lubiprostone—Tachycardia—Niacin—atherosclerosis	0.00187	0.00377	CcSEcCtD
Lubiprostone—Skin disorder—Niacin—atherosclerosis	0.00186	0.00376	CcSEcCtD
Lubiprostone—Dyspnoea—Simvastatin—atherosclerosis	0.00186	0.00375	CcSEcCtD
Lubiprostone—Hyperhidrosis—Niacin—atherosclerosis	0.00185	0.00374	CcSEcCtD
Lubiprostone—Feeling abnormal—Lovastatin—atherosclerosis	0.00183	0.00371	CcSEcCtD
Lubiprostone—Dyspepsia—Simvastatin—atherosclerosis	0.00183	0.00371	CcSEcCtD
Lubiprostone—Anorexia—Niacin—atherosclerosis	0.00182	0.00369	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00182	0.00368	CcSEcCtD
Lubiprostone—Hyperhidrosis—Pravastatin—atherosclerosis	0.00182	0.00368	CcSEcCtD
Lubiprostone—Decreased appetite—Simvastatin—atherosclerosis	0.00181	0.00366	CcSEcCtD
Lubiprostone—Feeling abnormal—Ezetimibe—atherosclerosis	0.0018	0.00364	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.0018	0.00364	CcSEcCtD
Lubiprostone—Diarrhoea—Rosuvastatin—atherosclerosis	0.0018	0.00364	CcSEcCtD
Lubiprostone—Fatigue—Simvastatin—atherosclerosis	0.0018	0.00363	CcSEcCtD
Lubiprostone—Anorexia—Pravastatin—atherosclerosis	0.00179	0.00363	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00179	0.00361	CcSEcCtD
Lubiprostone—Constipation—Simvastatin—atherosclerosis	0.00178	0.0036	CcSEcCtD
Lubiprostone—Pain—Simvastatin—atherosclerosis	0.00178	0.0036	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.00177	0.00722	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.00177	0.00722	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.00177	0.00722	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.00177	0.00722	CbGpPWpGaD
Lubiprostone—Abdominal pain—Lovastatin—atherosclerosis	0.00176	0.00356	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.00175	0.00713	CbGpPWpGaD
Lubiprostone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00174	0.00352	CcSEcCtD
Lubiprostone—Dizziness—Rosuvastatin—atherosclerosis	0.00174	0.00351	CcSEcCtD
Lubiprostone—Abdominal pain—Ezetimibe—atherosclerosis	0.00173	0.00349	CcSEcCtD
Lubiprostone—Feeling abnormal—Simvastatin—atherosclerosis	0.00172	0.00347	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00171	0.00347	CcSEcCtD
Lubiprostone—Dyspnoea—Niacin—atherosclerosis	0.0017	0.00345	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.0017	0.00344	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00169	0.00689	CbGpPWpGaD
Lubiprostone—Dyspepsia—Niacin—atherosclerosis	0.00168	0.0034	CcSEcCtD
Lubiprostone—Dyspnoea—Pravastatin—atherosclerosis	0.00168	0.00339	CcSEcCtD
Lubiprostone—Decreased appetite—Niacin—atherosclerosis	0.00166	0.00336	CcSEcCtD
Lubiprostone—Dyspepsia—Pravastatin—atherosclerosis	0.00166	0.00335	CcSEcCtD
Lubiprostone—Rash—Rosuvastatin—atherosclerosis	0.00166	0.00335	CcSEcCtD
Lubiprostone—Dermatitis—Rosuvastatin—atherosclerosis	0.00165	0.00335	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Niacin—atherosclerosis	0.00165	0.00334	CcSEcCtD
Lubiprostone—Abdominal pain—Simvastatin—atherosclerosis	0.00165	0.00333	CcSEcCtD
Lubiprostone—Headache—Rosuvastatin—atherosclerosis	0.00165	0.00333	CcSEcCtD
Lubiprostone—Hypersensitivity—Lovastatin—atherosclerosis	0.00164	0.00332	CcSEcCtD
Lubiprostone—Decreased appetite—Pravastatin—atherosclerosis	0.00164	0.00331	CcSEcCtD
Lubiprostone—Pain—Niacin—atherosclerosis	0.00163	0.00331	CcSEcCtD
Lubiprostone—Fatigue—Pravastatin—atherosclerosis	0.00162	0.00328	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00162	0.0066	CbGpPWpGaD
Lubiprostone—Pain—Pravastatin—atherosclerosis	0.00161	0.00326	CcSEcCtD
Lubiprostone—Constipation—Pravastatin—atherosclerosis	0.00161	0.00326	CcSEcCtD
Lubiprostone—Hypersensitivity—Ezetimibe—atherosclerosis	0.00161	0.00325	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PPARA—atherosclerosis	0.00161	0.00655	CbGpPWpGaD
Lubiprostone—Asthenia—Lovastatin—atherosclerosis	0.0016	0.00323	CcSEcCtD
Lubiprostone—Asthenia—Ezetimibe—atherosclerosis	0.00157	0.00317	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Niacin—atherosclerosis	0.00156	0.00316	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.00156	0.00636	CbGpPWpGaD
Lubiprostone—Nausea—Rosuvastatin—atherosclerosis	0.00156	0.00316	CcSEcCtD
Lubiprostone—Feeling abnormal—Pravastatin—atherosclerosis	0.00155	0.00314	CcSEcCtD
Lubiprostone—CBR1—Metabolism—LDLRAP1—atherosclerosis	0.00154	0.00628	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00154	0.00311	CcSEcCtD
Lubiprostone—Hypersensitivity—Simvastatin—atherosclerosis	0.00153	0.0031	CcSEcCtD
Lubiprostone—Diarrhoea—Lovastatin—atherosclerosis	0.00152	0.00308	CcSEcCtD
Lubiprostone—Abdominal pain—Niacin—atherosclerosis	0.00151	0.00306	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOA1—atherosclerosis	0.00151	0.00614	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.00151	0.00614	CbGpPWpGaD
Lubiprostone—Asthenia—Simvastatin—atherosclerosis	0.00149	0.00302	CcSEcCtD
Lubiprostone—Diarrhoea—Ezetimibe—atherosclerosis	0.00149	0.00302	CcSEcCtD
Lubiprostone—Abdominal pain—Pravastatin—atherosclerosis	0.00149	0.00301	CcSEcCtD
Lubiprostone—Dizziness—Lovastatin—atherosclerosis	0.00147	0.00298	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLTP—atherosclerosis	0.00145	0.0059	CbGpPWpGaD
Lubiprostone—Dizziness—Ezetimibe—atherosclerosis	0.00144	0.00292	CcSEcCtD
Lubiprostone—Diarrhoea—Simvastatin—atherosclerosis	0.00142	0.00288	CcSEcCtD
Lubiprostone—Vomiting—Lovastatin—atherosclerosis	0.00142	0.00286	CcSEcCtD
Lubiprostone—Hypersensitivity—Niacin—atherosclerosis	0.00141	0.00285	CcSEcCtD
Lubiprostone—Rash—Lovastatin—atherosclerosis	0.0014	0.00284	CcSEcCtD
Lubiprostone—Dermatitis—Lovastatin—atherosclerosis	0.0014	0.00284	CcSEcCtD
Lubiprostone—Headache—Lovastatin—atherosclerosis	0.00139	0.00282	CcSEcCtD
Lubiprostone—Vomiting—Ezetimibe—atherosclerosis	0.00139	0.00281	CcSEcCtD
Lubiprostone—Hypersensitivity—Pravastatin—atherosclerosis	0.00139	0.00281	CcSEcCtD
Lubiprostone—Dizziness—Simvastatin—atherosclerosis	0.00138	0.00278	CcSEcCtD
Lubiprostone—Rash—Ezetimibe—atherosclerosis	0.00138	0.00278	CcSEcCtD
Lubiprostone—Dermatitis—Ezetimibe—atherosclerosis	0.00138	0.00278	CcSEcCtD
Lubiprostone—Asthenia—Niacin—atherosclerosis	0.00137	0.00277	CcSEcCtD
Lubiprostone—Headache—Ezetimibe—atherosclerosis	0.00137	0.00277	CcSEcCtD
Lubiprostone—Asthenia—Pravastatin—atherosclerosis	0.00135	0.00273	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.00134	0.00547	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.00134	0.00544	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.00133	0.0054	CbGpPWpGaD
Lubiprostone—Vomiting—Simvastatin—atherosclerosis	0.00132	0.00268	CcSEcCtD
Lubiprostone—Nausea—Lovastatin—atherosclerosis	0.00132	0.00267	CcSEcCtD
Lubiprostone—Rash—Simvastatin—atherosclerosis	0.00131	0.00266	CcSEcCtD
Lubiprostone—Dermatitis—Simvastatin—atherosclerosis	0.00131	0.00265	CcSEcCtD
Lubiprostone—Diarrhoea—Niacin—atherosclerosis	0.00131	0.00265	CcSEcCtD
Lubiprostone—Headache—Simvastatin—atherosclerosis	0.0013	0.00264	CcSEcCtD
Lubiprostone—Nausea—Ezetimibe—atherosclerosis	0.0013	0.00262	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.0013	0.00528	CbGpPWpGaD
Lubiprostone—Diarrhoea—Pravastatin—atherosclerosis	0.00129	0.00261	CcSEcCtD
Lubiprostone—Dizziness—Niacin—atherosclerosis	0.00126	0.00256	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ABCG8—atherosclerosis	0.00126	0.00512	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LTA4H—atherosclerosis	0.00126	0.00512	CbGpPWpGaD
Lubiprostone—Dizziness—Pravastatin—atherosclerosis	0.00124	0.00252	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.00124	0.00505	CbGpPWpGaD
Lubiprostone—Nausea—Simvastatin—atherosclerosis	0.00124	0.0025	CcSEcCtD
Lubiprostone—Vomiting—Niacin—atherosclerosis	0.00122	0.00246	CcSEcCtD
Lubiprostone—Rash—Niacin—atherosclerosis	0.00121	0.00244	CcSEcCtD
Lubiprostone—Dermatitis—Niacin—atherosclerosis	0.0012	0.00244	CcSEcCtD
Lubiprostone—Headache—Niacin—atherosclerosis	0.0012	0.00242	CcSEcCtD
Lubiprostone—Vomiting—Pravastatin—atherosclerosis	0.0012	0.00242	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.0012	0.00487	CbGpPWpGaD
Lubiprostone—Rash—Pravastatin—atherosclerosis	0.00119	0.0024	CcSEcCtD
Lubiprostone—Dermatitis—Pravastatin—atherosclerosis	0.00119	0.0024	CcSEcCtD
Lubiprostone—Headache—Pravastatin—atherosclerosis	0.00118	0.00239	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.00117	0.00477	CbGpPWpGaD
Lubiprostone—Nausea—Niacin—atherosclerosis	0.00114	0.0023	CcSEcCtD
Lubiprostone—Nausea—Pravastatin—atherosclerosis	0.00112	0.00226	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.00104	0.00425	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFB1—atherosclerosis	0.00101	0.00412	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCG1—atherosclerosis	0.000994	0.00405	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FABP4—atherosclerosis	0.000935	0.00381	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LCAT—atherosclerosis	0.000935	0.00381	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA4—atherosclerosis	0.000917	0.00373	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP7A1—atherosclerosis	0.000901	0.00367	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000859	0.0035	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CYP27A1—atherosclerosis	0.000833	0.00339	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.00082	0.00334	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.0008	0.00326	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA2—atherosclerosis	0.00079	0.00322	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLA2G2A—atherosclerosis	0.00079	0.00322	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALOX5AP—atherosclerosis	0.00079	0.00322	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALOX15—atherosclerosis	0.00079	0.00322	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCG5—atherosclerosis	0.00078	0.00318	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000779	0.00317	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LPA—atherosclerosis	0.000753	0.00307	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—BGN—atherosclerosis	0.00073	0.00297	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000724	0.00295	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA5—atherosclerosis	0.000722	0.00294	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000702	0.00286	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PLA2G1B—atherosclerosis	0.000695	0.00283	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000687	0.0028	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000681	0.00277	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000679	0.00277	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALOX5—atherosclerosis	0.000671	0.00273	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.00062	0.00253	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NAMPT—atherosclerosis	0.000602	0.00245	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000599	0.00244	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LIPC—atherosclerosis	0.000598	0.00244	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOC3—atherosclerosis	0.000595	0.00242	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LDLR—atherosclerosis	0.000591	0.00241	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CETP—atherosclerosis	0.000577	0.00235	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SCARB1—atherosclerosis	0.000553	0.00225	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000538	0.00219	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMGCR—atherosclerosis	0.000522	0.00213	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000471	0.00192	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ABCA1—atherosclerosis	0.000465	0.00189	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMOX1—atherosclerosis	0.000399	0.00163	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOB—atherosclerosis	0.000382	0.00156	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTM1—atherosclerosis	0.000372	0.00151	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—LPL—atherosclerosis	0.000365	0.00149	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GPX1—atherosclerosis	0.000356	0.00145	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CD36—atherosclerosis	0.000347	0.00141	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTHFR—atherosclerosis	0.000329	0.00134	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARA—atherosclerosis	0.000323	0.00131	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AGT—atherosclerosis	0.000312	0.00127	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOE—atherosclerosis	0.000306	0.00125	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CAV1—atherosclerosis	0.000303	0.00123	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA1—atherosclerosis	0.000303	0.00123	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CG—atherosclerosis	0.000276	0.00112	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARG—atherosclerosis	0.000267	0.00109	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—INS—atherosclerosis	0.000262	0.00106	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALB—atherosclerosis	0.00024	0.000976	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NOS3—atherosclerosis	0.000229	0.000934	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—atherosclerosis	0.00021	0.000854	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—AKT1—atherosclerosis	0.000105	0.000429	CbGpPWpGaD
